[Swedish research in hypertension].

Area of Science:

• Cardiovascular Medicine
• Clinical Pharmacology
• Public Health

Context:

• Swedish hypertension research spans nearly a century, evolving from early syndrome descriptions to modern drug therapies and clinical trials.
• Pioneering work by Kylin, Hood, Werkö, Folkow, and Hansson has significantly contributed to understanding hypertension.
• Hypertension affects a substantial patient group in Sweden (700,000 treated), highlighting the need for effective management.

Purpose:

• To provide a historical overview of hypertension research in Sweden.
• To highlight key contributions and researchers in the field.
• To underscore the ongoing need for research into optimal long-term hypertension management strategies.

Summary:

• Research began in the 1920s with Eskil Kylin's work on hypertension as a metabolic syndrome.
• Modern drug therapy for malignant hypertension was initiated in the 1950s by Bertil Hood.
• Recent contributions include arterial wall modeling studies and large-scale randomized clinical trials in hypertensive patients.

Impact:

• Swedish researchers have made significant advancements in understanding hypertension's pathophysiology and treatment.
• The ongoing research aims to establish the most beneficial and cost-effective long-term therapies.
• Continued investigation is crucial for improving the management of the largest patient group in Sweden.